María Vittoria Di Tomaso, Eric Gregoire, Wilner Martínez-López
{"title":"Effects of Valproic Acid on Radiation-Induced Chromosomal Aberrations in Human Lymphocytes.","authors":"María Vittoria Di Tomaso, Eric Gregoire, Wilner Martínez-López","doi":"10.4103/2041-9414.198909","DOIUrl":null,"url":null,"abstract":"<p><p>One of the most widely employed histone deacetylases inhibitors in the clinic is the valproic acid (VA), proving to have a good tolerance and low side effects on human health. VA induces changes in chromatin structure making DNA more susceptible to damage induction and influence DNA repair efficiency. VA is also proposed as a radiosensitizing agent. To know if VA is suitable to sensitize human lymphocytes γ-irradiation <i>in vitro</i>, different types of chromosomal aberrations in the lymphocytes, either in the absence or presence of VA, were analyzed. For this purpose, blood samples from four healthy donors were exposed to γ-rays at a dose of 1.5 Gy and then treated with two different doses of VA (0.35 or 0.70 mM). Unstable and stable chromosomal aberrations were analyzed by means of fluorescence <i>in situ</i> hybridization. Human lymphocytes treated with VA alone did not show any increase in the frequency of chromosomal aberrations. However, a moderate degree of sensitization was observed, through the increase of chromosomal aberrations, when 0.35 mM VA was employed after γ-irradiation, whereas 0.70 mM VA did not modify chromosomal aberration frequencies. The lower number of chromosomal aberrations obtained when VA was employed at higher dose after γ-irradiation, could be related to the induction of a cell cycle arrest, a fact that should be taken into consideration when VA is employed in combination with physical or chemical agents.</p>","PeriodicalId":53596,"journal":{"name":"Genome Integrity","volume":"8 ","pages":"4"},"PeriodicalIF":0.0000,"publicationDate":"2017-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/21/65/GI-8-4.PMC5320781.pdf","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Genome Integrity","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/2041-9414.198909","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 3
Abstract
One of the most widely employed histone deacetylases inhibitors in the clinic is the valproic acid (VA), proving to have a good tolerance and low side effects on human health. VA induces changes in chromatin structure making DNA more susceptible to damage induction and influence DNA repair efficiency. VA is also proposed as a radiosensitizing agent. To know if VA is suitable to sensitize human lymphocytes γ-irradiation in vitro, different types of chromosomal aberrations in the lymphocytes, either in the absence or presence of VA, were analyzed. For this purpose, blood samples from four healthy donors were exposed to γ-rays at a dose of 1.5 Gy and then treated with two different doses of VA (0.35 or 0.70 mM). Unstable and stable chromosomal aberrations were analyzed by means of fluorescence in situ hybridization. Human lymphocytes treated with VA alone did not show any increase in the frequency of chromosomal aberrations. However, a moderate degree of sensitization was observed, through the increase of chromosomal aberrations, when 0.35 mM VA was employed after γ-irradiation, whereas 0.70 mM VA did not modify chromosomal aberration frequencies. The lower number of chromosomal aberrations obtained when VA was employed at higher dose after γ-irradiation, could be related to the induction of a cell cycle arrest, a fact that should be taken into consideration when VA is employed in combination with physical or chemical agents.
丙戊酸(VA)是临床应用最广泛的组蛋白去乙酰化酶抑制剂之一,对人体健康具有良好的耐受性和低的副作用。VA诱导染色质结构的变化,使DNA更容易受到损伤诱导,影响DNA修复效率。VA也被认为是一种放射增敏剂。为了了解VA是否适合体外致敏人淋巴细胞γ-辐照,我们分析了在没有VA或有VA的情况下淋巴细胞中不同类型的染色体畸变。为此,将4名健康献血者的血液样本暴露在1.5 Gy剂量的γ射线中,然后用两种不同剂量的VA(0.35或0.70 mM)进行处理。用荧光原位杂交法分析不稳定和稳定染色体畸变。单独用VA治疗的人淋巴细胞没有显示出染色体畸变频率的增加。然而,当γ辐照后使用0.35 mM VA时,通过增加染色体畸变,观察到中等程度的致敏作用,而0.70 mM VA没有改变染色体畸变频率。在γ辐照后以较高剂量使用VA时,获得的染色体畸变数较低,这可能与诱导细胞周期阻滞有关,当VA与物理或化学剂联合使用时,应考虑到这一事实。